% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Hemminki:186237,
      author       = {K. Hemminki$^*$ and A. Försti$^*$},
      title        = {{I}ncidence, {M}ortality and {S}urvival {T}rends in
                      {B}reast {C}ancers {C}oincident with {I}ntroduction of
                      {M}ammography in the {N}ordic {C}ountries.},
      journal      = {Cancers},
      volume       = {14},
      number       = {23},
      issn         = {2072-6694},
      address      = {Basel},
      publisher    = {MDPI},
      reportid     = {DKFZ-2022-03034},
      pages        = {5907},
      year         = {2022},
      note         = {#EA:C020#LA:B062#},
      abstract     = {Survival in female breast cancers has generally improved
                      but the relative contribution of early detection or
                      treatment in this positive development is not known. Our aim
                      was to assess the possible role of national mammography
                      screening programs in survival improvement. Such screening
                      has been offered to women, usually at 50-69 years of age, in
                      Finland and Sweden since the 1980s and in Denmark and Norway
                      since the 1990s. Participation rates have been high, ranging
                      from $60\%$ to $90\%.$ We analyzed incidence and mortality
                      changes and relative 5- and 10-year survival trends in
                      breast cancer as novel measures in these countries using the
                      NORDCAN database. Survival trends were compared in age
                      groups of women who were screened to those who were not
                      screened. We observed a relative survival advantage in
                      5-year and 10-year survival in the screened age groups after
                      the period of national mammography screening was in place
                      and this was consistent in each country. Timing and
                      age-specific targeting of the improvements suggest that
                      mammography may have contributed to the survival benefits.
                      However, as we had no individual data on women who used the
                      service, more detailed studies are needed to confirm the
                      suggested survival advantage, particularly concerning
                      mortality in stage-specific breast cancer.},
      keywords     = {cancer control (Other) / mammography (Other) / periodic
                      survival (Other) / treatment (Other)},
      cin          = {C020 / B062 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)C020-20160331 / I:(DE-He78)B062-20160331 /
                      I:(DE-He78)HD01-20160331},
      pnm          = {312 - Funktionelle und strukturelle Genomforschung
                      (POF4-312)},
      pid          = {G:(DE-HGF)POF4-312},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:36497389},
      doi          = {10.3390/cancers14235907},
      url          = {https://inrepo02.dkfz.de/record/186237},
}